Literature DB >> 3124995

Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.

E Brummer1, D A Stevens.   

Abstract

The ability of murine recombinant gamma interferon (IFN) or lymphokines to enhance the fungicidal activity of murine pulmonary macrophages (PuM) was studied in in vitro. PuM monolayers were incubated overnight with IFN, lymph node cells (LNC) plus concanavalin A, supernatants from Con A stimulated LNC or spleen cell cultures (Con A Sup), or tissue culture medium (TCM) +/- Con A (5 micrograms/ml) or +/- lipopolysaccharide (LPS, 10 ng to 10 micrograms/ml). After treatment, culture fluids were removed and PuM were challenged for 4 h with the yeast-form Blastomyces dermatitidis or 2 h with Candida albicans. Inoculum colony forming units (CFU) of B. dermatitidis were significantly reduced by PuM treated with 1000 U/ml of IFN (25 +/- 3%), Con A Sup (25 +/- 3%) or LNC plus Con A (37-44%), but not by TCM, ConA or LPS. Candida albicans was killed by PuM treated with Con A Sup (33 +/- 8%) or LNC plus Con A (30-43%), but not by TCM, Con A, or LPS, and the activity of Con A Sup was neutralized by anti-IFN antibody. Candida albicans was not significantly killed by PuM treated with IFN doses ranging from 1 to 10(5) U/ml; nor did addition of LPS to IFN, or prolonged (3 day) treatment with IFN, result in significant killing of C. albicans by PuM. However, IFN (100 U/ml) could activate resident peritoneal macrophages for significant candidacidal activity (63%). These data indicate that PuM can be activated for fungicidal activity, and that PuM differ from resident peritoneal macrophages with regard to induction of candidacidal activity by recombinant gamma-IFN.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124995      PMCID: PMC1542173     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.

Authors:  G J Jakab
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

2.  Characterization of murine lung and peritoneal macrophages.

Authors:  J E Hearst; G A Warr; G J Jakab
Journal:  J Reticuloendothel Soc       Date:  1980-05

3.  Activation of alveolar macrophages after lower respiratory tract infection.

Authors:  J D Johnson; W L Hand; N L King; C G Hughes
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

4.  Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.

Authors:  C Bordignon; R Avallone; G Peri; N Polentarutti; C Mangioni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

5.  Interaction of alveolar macrophages with Nocardia asteroides: immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity.

Authors:  C Davis-Scibienski; B L Beaman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.

Authors:  S Sone; I J Fidler
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

7.  Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans.

Authors:  R I Lehrer; L G Ferrari; J Patterson-Delafield; T Sorrell
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  In vitro response of alveolar macrophages to infection with Coccidioides immitis.

Authors:  L Beaman; C A Holmberg
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  THE PARTICULATE HYDROLASES OF MACROPHAGES. I. COMPARATIVE ENZYMOLOGY, ISOLATION, AND PROPERTIES.

Authors:  Z A COHN; E WIENER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

10.  Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.

Authors:  R W Leu; A L Eddleston; J W Hadden; R A Good
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  15 in total

1.  Induction of anti-mycobacterial and anti-listerial activity of human monocytes requires different activation signals.

Authors:  G Zerlauth; M M Eibl; J W Mannhalter
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.

Authors:  C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 4.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 5.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

6.  Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase.

Authors:  Nicole M Rocco; John C Carmen; Bruce S Klein
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

7.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver.

Authors:  R T Sawyer; R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Evasion of innate immune responses: evidence for mannose binding lectin inhibition of tumor necrosis factor alpha production by macrophages in response to Blastomyces dermatitidis.

Authors:  Adi Koneti; Michael J Linke; Elmer Brummer; David A Stevens
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.